ALCL accounts for approximately 15% of pediatric non-Hodgkin lymphoma (NHL) cases [168], with the majority being associated with the t(2;5) translocation, leading to expression of the tyrosine kinase ALK. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.